Crossmark Global Holdings’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$211K Buy
2024
Q3
Sell
2024
Q2
$319K Sell
2024
Q1
$427K Sell
2023
Q4
$587K Hold
2023
Q3
$445K Buy
2023
Q2
$466K Buy
2023
Q1
$415K Sell
2022
Q4
$405K Buy
2022
Q3
$325K Buy
2022
Q2
$340K Buy